{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:27:41Z","timestamp":1777926461430,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"9169","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1016\/s0140-6736(99)04440-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T15:44:57Z","timestamp":1027611897000},"page":"2001-2007","source":"Crossref","is-referenced-by-count":4149,"title":["Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)"],"prefix":"10.1016","volume":"353","member":"78","reference":[{"key":"10.1016\/S0140-6736(99)04440-2_bib1","first-page":"2","article-title":"Consensus recommendations for the management of chronic heart failure","volume":"83","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0140-6736(99)04440-2_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(99)04440-2_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejections fraction and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(99)04440-2_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(99)04440-2_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/hrt.37.10.1022","article-title":"Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy","volume":"37","author":"Waagstein","year":"1975","journal-title":"Br Heart J"},{"key":"10.1016\/S0140-6736(99)04440-2_bib6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0140-6736(79)92010-5","article-title":"Prolongation of survival in congestive cardiomyopathy by btT-receptor blockade","volume":"i","author":"Swedberg","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(99)04440-2_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/hrt.50.2.135","article-title":"Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction","volume":"50","author":"Gundersen","year":"1983","journal-title":"Br Heart J"},{"key":"10.1016\/S0140-6736(99)04440-2_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.CIR.73.3.503","article-title":"Effect of propranolol after acute myocardial infarction in patients with congestive heart failure","volume":"73","author":"Chadda","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(99)04440-2_bib9","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","article-title":"Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy","volume":"342","author":"Waagstein","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(99)04440-2_bib10","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","article-title":"A randomized trial of btT-blockade in heart failure: the cardiac insufficiency bisoprolol study (CIBIS)","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(99)04440-2_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(99)04440-2_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(97)80008-6","article-title":"Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"suppl","key":"10.1016\/S0140-6736(99)04440-2_bib13","first-page":"307","article-title":"Metoprolol prevents left ventricular dilatation and increase exercise ejection fraction to the same extent in idiopathic and ischemic cardiomyopathy","volume":"19","author":"Waagstein","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(99)04440-2_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0002-9149(97)00841-2","article-title":"Rationale, design, and organisation of the metoprolol CR\/XL randomized trial in heart failure (MERIT-HF)","volume":"80","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0140-6736(99)04440-2_bib15","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/oxfordjournals.eurheartj.a015074","article-title":"Mode of death in chronic heart failure, a request and proposition for more accurate classification","volume":"17","author":"Narang","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(99)04440-2_bib16","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/oxfordjournals.eurheartj.a014745","article-title":"Beta-blocking agents in heart failure: should they be used and how?","volume":"17","author":"Cleland","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(99)04440-2_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/oxfordjournals.eurheartj.a015297","article-title":"Effects of beta-blocker therapy on mortality in patients with heart failure","volume":"18","author":"Doughty","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(99)04440-2_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0735-1097(97)00104-6","article-title":"Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials","volume":"30","author":"Heydenrich","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(99)04440-2_bib19","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS II)","volume":"****","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(99)04440-2_bib20","series-title":"Heart failure in clinical practice","first-page":"189","article-title":"Arrhytmias and sudden death in heart failure: can we prevent them?","author":"Rankin","year":"1996"},{"key":"10.1016\/S0140-6736(99)04440-2_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/oxfordjournals.eurheartj.a060043","article-title":"Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials","volume":"13","author":"Olsson","year":"1992","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(99)04440-2_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ajh\/4.2.151","article-title":"Primary prevention of sudden cardiovascular death in hypertensive patients: mortality results from the MAPHY study","volume":"4","author":"Olsson","year":"1991","journal-title":"Am J Hypertens"},{"issue":"suppl D","key":"10.1016\/S0140-6736(99)04440-2_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/13.suppl_D.111-b","article-title":"The role of beta receptor blockade in preventing sudden death","volume":"13","author":"Wikstrand","year":"1992","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(99)04440-2_bib24","doi-asserted-by":"crossref","unstructured":"Goldstein A, Kennedy HL, Hall C, et al. Extended release metoprolol CR\/XL in patients with heart failure: a pilot study examining the tolerability, safety and effect on left ventricular ejection fraction. Am Heart J 1999 (in press).","DOI":"10.1016\/S0002-8703(99)70083-9"},{"key":"10.1016\/S0140-6736(99)04440-2_bib25","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(05)79125-X","article-title":"3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial","volume":"351","year":"1998","journal-title":"Lancet"},{"issue":"suppl","key":"10.1016\/S0140-6736(99)04440-2_bib26","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF00578405","article-title":"Design of a new multiple-unit controlled-release formulation of metoprolol: metoprolol CR\/XL","volume":"33","author":"Sandberg","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/S0140-6736(99)04440-2_bib27","first-page":"183A","article-title":"The effect on heart rate of immediate and slow-release metoprolol in patients with chronic heart failure","volume":"33","author":"Andersson","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(99)04440-2_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0002-9149(97)00838-2","article-title":"Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (A subgroup analysis of the G\u00f6teborg Metoprolol Trial)","volume":"80","author":"Herlitz","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0140-6736(99)04440-2_bib29","doi-asserted-by":"crossref","unstructured":"Herlitz J, Dellborg M, Karlson BW, et al. Similar risk reducing effect of extended release metoprolol once daily and immediate release metoprolol twice daily during 5 years after myocardial infarction. Cardiovasc Drugs Ther 1999 (in press).","DOI":"10.1023\/A:1007736226093"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673699044402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673699044402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T21:51:35Z","timestamp":1556315495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673699044402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":29,"journal-issue":{"issue":"9169","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S0140673699044402"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(99)04440-2","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}